Synthesis, Anti‐ Leishmania amazonensis Activity, Cytotoxicity, and Molecular Docking of Anthranilate–Naphthoquinone Hybrids
ChemistrySelect · 2026-10 · 11 (40)
DOI: 10.1002/slct.74918 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 22.10.2026. Verfasst von Eduardo Miranda da Silva Magesfeste und 7 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Neglected tropical diseases affect over one billion people globally, with leishmaniasis remaining a major health challenge. This study describes the synthesis and in vitro biological evaluation of ten novel anthranilate–naphthoquinone hybrids as potential anti‐ Leishmania amazonensis agents. Isatoic anhydrides were synthesized from substituted isatins and subsequently coupled with aminonaphthoquinones via ethyl and propyl spacers, yielding compounds in 61%–98%. All were screened in vitro against promastigote forms, with iodinated/brominated derivatives with ethyl/propyl spacers showing the most promising activity profiles. Moreover, moderate in vitro potency against intracellular amastigotes infecting murine (mouse) macrophages was observed for 2‐((1,4‐naphthoquinyl)amino)ethyl‐2‐amino‐5‐bromobenzoate (IC 50 = 30.5 µM) and its propyl analogue (IC 50 = 31 µM). Both compounds exhibited low cytotoxicity (CC 50 > 250 µM), supporting a favorable selectivity profile (selectivity index, SI > 8.00). Although miltefosine, the reference oral anti‐ Leishmania drug, is still more potent in vitro and has a higher selectivity index (SI > 17.6), its clinical toxicity and resistence highlights the need for safer alternatives. Consensus docking of these two compounds pointed trypanothione reductase, leishmanolysin (or glycoprotein 63, GP63), and pteridine reductase from L. amazonensis as potential target enzymes. These findings highlight brominated anthranilate–naphthoquinones as promising structures for further optimization toward the development of new anti‐ Leishmania agents.
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Magesfeste, E. M. D. S., Hamerski, L., Nunes, D. M., Ribeiro, A. P. S. D. S., Saraiva, E. M., Albuquerque, M. G., Lima, C. H. D. S., & Silva, B. V. D. (2026). Synthesis, Anti‐ Leishmania amazonensis Activity, Cytotoxicity, and Molecular Docking of Anthranilate–Naphthoquinone Hybrids. ChemistrySelect, 11(40). https://doi.org/10.1002/slct.74918
Vancouver
Magesfeste EMDS, Hamerski L, Nunes DM, Ribeiro APSDS, Saraiva EM, Albuquerque MG, et al. Synthesis, Anti‐ Leishmania amazonensis Activity, Cytotoxicity, and Molecular Docking of Anthranilate–Naphthoquinone Hybrids. ChemistrySelect. 2026;11(40). doi:10.1002/slct.74918
BibTeX
@article{Magesfeste2026,
author = {Magesfeste, Eduardo Miranda da Silva and Hamerski, Lidilhone and Nunes, Diego Mendes and Ribeiro, Ana Paula Sotero da Silva and Saraiva, Elvira Maria and Albuquerque, Magaly Girão and Lima, Camilo Henrique da Silva and Silva, Bárbara Vasconcellos da},
title = {Synthesis, Anti‐ Leishmania amazonensis Activity, Cytotoxicity, and Molecular Docking of Anthranilate–Naphthoquinone Hybrids},
journal = {ChemistrySelect},
year = {2026},
volume = {11},
number = {40},
doi = {10.1002/slct.74918}
}
EUVIMED